Results     18-May-20
Announcements
Astrazeneca Pharma India standalone net profit declines 2.44% in the March 2020 quarter
Sales rise 2.42% to Rs 194.90 crore
Net profit of Astrazeneca Pharma India declined 2.44% to Rs 9.58 crore in the quarter ended March 2020 as against Rs 9.82 crore during the previous quarter ended March 2019. Sales rose 2.42% to Rs 194.90 crore in the quarter ended March 2020 as against Rs 190.30 crore during the previous quarter ended March 2019.

For the full year,net profit rose 32.64% to Rs 72.21 crore in the year ended March 2020 as against Rs 54.44 crore during the previous year ended March 2019. Sales rose 14.21% to Rs 831.81 crore in the year ended March 2020 as against Rs 728.29 crore during the previous year ended March 2019.

ParticularsQuarter EndedYear Ended
 Mar. 2020Mar. 2019% Var.Mar. 2020Mar. 2019% Var.
Sales194.90190.30 2 831.81728.29 14
OPM %7.593.35 -14.519.79 -
PBDT17.8912.38 45 132.5487.58 51
PBT13.358.47 58 113.9672.66 57
NP9.589.82 -2 72.2154.44 33

Previous News
  Board of Astrazeneca Pharma India recommends interim dividend
 ( Corporate News - 09-Aug-21   20:10 )
  AstraZeneca Pharma gets CDSCO nod for Dapagliflozin tablets
 ( Hot Pursuit - 28-Nov-22   10:12 )
  AstraZeneca Pharma receives DCGI approves to import pharmaceutical formulation for Dapagliflozin Tablets
 ( Corporate News - 24-Jul-23   18:05 )
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 10-Aug-21   10:00 )
  Astrazeneca Pharma advances after turnaround Q4 result
 ( Hot Pursuit - 22-May-18   10:24 )
  Astrazeneca Pharma India fixes record date for final dividend
 ( Market Beat - Reports 26-Jun-24   09:51 )
  Astrazeneca Pharma India schedules board meeting
 ( Corporate News - 25-May-23   15:01 )
  Astrazeneca Pharma India standalone net profit declines 66.65% in the September 2018 quarter
 ( Results - Announcements 14-Nov-18   16:20 )
  AstraZeneca Pharma India terminates its distribution agreement with Abbott Healthcare
 ( Corporate News - 28-May-21   12:00 )
  Astrazeneca Pharma gains after CDSCO nod to sale Tremelimumab solution
 ( Hot Pursuit - 02-Jun-23   10:05 )
  AstraZeneca Pharma India announces appointment of director
 ( Corporate News - 04-Nov-14   16:25 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top